HomeCompareCHFFY vs JNJ

CHFFY vs JNJ: Dividend Comparison 2026

CHFFY yields 4.16% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHFFY wins by $1.8K in total portfolio value
10 years
CHFFY
CHFFY
● Live price
4.16%
Share price
$6.45
Annual div
$0.27
5Y div CAGR
-22.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.8K
Annual income
$35.04
Full CHFFY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CHFFY vs JNJ

📍 CHFFY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHFFYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHFFY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHFFY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHFFY
Annual income on $10K today (after 15% tax)
$353.24/yr
After 10yr DRIP, annual income (after tax)
$29.78/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $673.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHFFY + JNJ for your $10,000?

CHFFY: 50%JNJ: 50%
100% JNJ50/50100% CHFFY
Portfolio after 10yr
$20.9K
Annual income
$431.41/yr
Blended yield
2.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CHFFY
No analyst data
Altman Z
0.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHFFY buys
0
JNJ buys
0
No recent congressional trades found for CHFFY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHFFYJNJ
Forward yield4.16%3.36%
Annual dividend / share$0.27$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-22.7%5.8%
Portfolio after 10y$21.8K$20.0K
Annual income after 10y$35.04$827.78
Total dividends collected$1.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHFFY vs JNJ ($10,000, DRIP)

YearCHFFY PortfolioCHFFY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,021$321.24$10,676$355.77+$345.00CHFFY
2$12,049$255.78$11,407$389.39+$642.00CHFFY
3$13,094$202.00$12,198$426.53+$896.00CHFFY
4$14,169$158.60$13,056$467.62+$1.1KCHFFY
5$15,285$123.98$13,987$513.12+$1.3KCHFFY
6$16,451$96.62$14,998$563.56+$1.5KCHFFY
7$17,678$75.13$16,098$619.52+$1.6KCHFFY
8$18,974$58.32$17,295$681.69+$1.7KCHFFY
9$20,347$45.22$18,599$750.82+$1.7KCHFFY
10$21,807$35.04$20,022$827.78+$1.8KCHFFY

CHFFY vs JNJ: Complete Analysis 2026

CHFFYStock

China Everbright Environment Group Limited, provides environmental solutions worldwide. The company's Environmental Energy Project Construction and Operation segment constructs and operates food waste and leachate treatment, sludge treatment and disposal, methane-to-energy, fecal treatment, fly ash landfill, medical waste treatment, and solid waste treatment projects, as well as waste-to-energy plants. Its Greentech Project Construction and Operation segment constructs and operates integrated biomass utilization, hazardous and solid waste treatment, and solar energy and wind power projects, as well as offers environmental remediation services. The company's Environmental Water Project Construction and Operation segment constructs, upgrades, and operates waste water treatment, water supply, reusable water and sludge harmless treatment, sponge city construction, river-basin ecological restoration, waste water source heat pump, and leachate treatment projects. This segment also researches and develops water environment technologies and engineering projects. Its Others segment conducts environmental protection technology research and development projects; provides environmental related technological, and protection project equipment construction and installation services; designs environmental protection projects; and sells related equipment. This segment also offers waste sorting, renewable resources utilization, and sanitation operation services; sells energy-saving street lamps; and provides energy management contract projects. It also operates biomass electricity and heat cogeneration projects; and collects and treats municipal wastes. The company was formerly known as China Everbright International Limited and changed its name to China Everbright Environment Group Limited in September 2020. The company was incorporated in 1961 and is headquartered in Hong Kong, Hong Kong.

Full CHFFY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CHFFY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHFFY vs SCHDCHFFY vs JEPICHFFY vs OCHFFY vs KOCHFFY vs MAINCHFFY vs ABBVCHFFY vs MRKCHFFY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.